Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Tewodros Eguale"'
Autor:
Tewodros Eguale, François Bastardot, Wenyu Song, Daniel Motta-Calderon, Yasmin Elsobky, Angela Rui, Marlika Marceau, Clark Davis, Sandya Ganesan, Ava Alsubai, Michele Matthews, Lynn A Volk, David W Bates, Ronen Rozenblum
Publikováno v:
JMIR Medical Informatics, Vol 12, Pp e53625-e53625 (2024)
Abstract BackgroundDespite restrictive opioid management guidelines, opioid use disorder (OUD) remains a major public health concern. Machine learning (ML) offers a promising avenue for identifying and alerting clinicians about OUD, thus supporting
Externí odkaz:
https://doaj.org/article/f1f7cdb3c72342ed9a277f87a2bc6225
Publikováno v:
Pharmacy, Vol 12, Iss 4, p 124 (2024)
In the United States, Doctor of Pharmacy (PharmD) programs are required to provide advanced pharmacy practice experiences (APPEs) in the core inpatient rotation areas of hospital/health system pharmacy and inpatient general medicine patient care. Col
Externí odkaz:
https://doaj.org/article/7e7b355124424d51a260a864b873296d
Detection of adverse drug events in e-prescribing and administrative health data: a validation study
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Administrative health data are increasingly used to detect adverse drug events (ADEs). However, the few studies evaluating diagnostic codes for ADE detection demonstrated low sensitivity, likely due to narrow code sets, physician
Externí odkaz:
https://doaj.org/article/fac50e9095c044419a87ba92723aa857
Publikováno v:
Pharmacy, Vol 10, Iss 5, p 122 (2022)
Onsite and in-person experiential education has been well established to prepare practice-ready healthcare professionals, such as pharmacists. From COVID-19, the integration of remote educational delivery has occurred. As healthcare disciplines adjus
Externí odkaz:
https://doaj.org/article/afc2ad080aff4fefa95f64b02e87d906
Autor:
Mirica Maria, Khazen Maram, Hussein Sarib, Ramos Jason, Tewodros Eguale, Linzer Mark, Schiff D. Gordon
Publikováno v:
Journal of General Internal Medicine.
Publikováno v:
Journal of Alzheimer's Disease Reports
Background: Pharmacological treatment of Alzheimer’s disease (AD) involves symptomatic improvement of cognition using cholinesterase inhibitors (ChEIs) and memantine. The cost-effectiveness of these medications will guide decision-makers in making
Autor:
Hussein M. Farag, Ismaeel Yunusa, Hardik Goswami, Ihtisham Sultan, Joanne A. Doucette, Tewodros Eguale
Publikováno v:
JAMA network open. 5(5)
Amitriptyline is an established medication used off-label for the treatment of fibromyalgia, but pregabalin, duloxetine, and milnacipran are the only pharmacological agents approved by the US Food and Drug Administration (FDA) to treat fibromyalgia.T
Publikováno v:
Circulation. 144
Background: Direct oral anticoagulants (DOAC) have proven to be safe and effective alternatives to warfarin for stroke prevention in non-valvular atrial fibrillation (NVAF) as well as treatment of venous thromboembolism (VTE). Chronic kidney disease
Autor:
Monica, Fahmy, Katelyn W, Sylvester, Mattia, Migliore, Tewodros, Eguale, John, Fanikos, Jean M, Connors, Samuel Z, Goldhaber
Publikováno v:
Journal of thrombosis and thrombolysis. 52(1)
Patients hospitalized for an acute medical illness remain at risk of developing venous thromboembolism (VTE) post-discharge. Betrixaban, an oral direct Factor Xa inhibitor, is approved for extended VTE thromboprophylaxis in acutely ill medical patien
Detection of adverse drug events in e-prescribing and administrative health data: a validation study
Publikováno v:
BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Health Services Research, Vol 21, Iss 1, Pp 1-12 (2021)
Background Administrative health data are increasingly used to detect adverse drug events (ADEs). However, the few studies evaluating diagnostic codes for ADE detection demonstrated low sensitivity, likely due to narrow code sets, physician under-rec